Immatics is Biotechnology in Germany that focus on TCR Bispecifics business. Founded in 2000. They cover business area such as Immatics NV, true target, cancer immunotherapy, two lead product class, Adoptive Cell therapy, actengine, antibody-like TCR Bispecifics, TCER, each therapeutic modality, distinct attribute, patient, different disease stage, different type, tumor, particularly hard-to-treat solid cancer.
2000
( 26 years old in 2026 )
TCR Bispecifics
-
Paul-Ehrlich-Street 15
72076 Tübingen
Germany
Private
Immatics NVtrue targetcancer immunotherapytwo lead product classAdoptive Cell therapyactengineantibody-like TCR BispecificsTCEReach therapeutic modalitydistinct attributepatientdifferent disease stagedifferent typetumorparticularly hard-to-treat solid cancer
* We use standard office opening hours in near Immatics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immatics is Biotechnology business from Germany that founded in 2000 (26 years old in 2026), Immatics business is focusing on TCR Bispecifics.
Immatics headquarter office and corporate office address is located in Paul-Ehrlich-Street 15 72076 Tübingen Germany.
Immatics was founded in Germany.
In 2026, Immatics is currently focus on TCR Bispecifics sector.
Above is snippet of Google Trends for "TCR Bispecifics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immatics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
